First Tracks Biotherapeutics Inc (TRAX) Stock Analysis

What First Tracks Biotherapeutics Inc does

First Tracks Biotherapeutics, Inc., situated in San Diego, California, specializes in pioneering new immunology-based treatments. The firm is actively involved in the discovery and progression of therapeutics aimed at combating autoimmune and inflammatory disorders, currently advancing programs like rosnilimab, ANB033, and ANB101 through their clinical stages.

Key metrics

ETFs linked to TRAX

Broad-market and Healthcare sector ETFs an investor holding First Tracks Biotherapeutics Inc is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how TRAX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for First Tracks Biotherapeutics Inc?

First Tracks Biotherapeutics Inc trades under the ticker TRAX on NASDAQ.

Which exchange is TRAX listed on?

TRAX is listed on NASDAQ.

What sector does First Tracks Biotherapeutics Inc operate in?

First Tracks Biotherapeutics Inc is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze TRAX in a portfolio?

PortView shows TRAX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.